Union Bancaire Privee UBP SA Has $4.11 Million Stake in Ventas, Inc. $VTR

Union Bancaire Privee UBP SA raised its position in Ventas, Inc. (NYSE:VTR) by 191.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 50,281 shares of the real estate investment trust’s stock after buying an additional 33,030 shares during the quarter. Union Bancaire Privee UBP SA’s holdings in Ventas were worth $4,112,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in VTR. Vanguard Group Inc. lifted its holdings in shares of Ventas by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock worth $5,876,856,000 after acquiring an additional 2,349,176 shares during the period. State Street Corp raised its position in Ventas by 2.5% during the fourth quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock valued at $2,309,234,000 after purchasing an additional 735,620 shares in the last quarter. Geode Capital Management LLC raised its position in Ventas by 3.8% during the fourth quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock valued at $1,001,447,000 after purchasing an additional 475,633 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its stake in Ventas by 27.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 9,176,254 shares of the real estate investment trust’s stock worth $710,060,000 after purchasing an additional 2,000,341 shares during the last quarter. Finally, Capital World Investors bought a new stake in Ventas during the fourth quarter worth $594,116,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Ventas Stock Up 1.9%

Shares of NYSE:VTR opened at $89.06 on Friday. The company has a fifty day moving average of $85.21 and a 200-day moving average of $82.79. The company has a market capitalization of $43.30 billion, a PE ratio of 161.92, a price-to-earnings-growth ratio of 1.91 and a beta of 0.71. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. Ventas, Inc. has a 52-week low of $61.76 and a 52-week high of $91.06.

Ventas (NYSE:VTR) last announced its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the company posted $0.84 earnings per share. The firm’s revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities analysts predict that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be given a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 annualized dividend and a yield of 2.3%. Ventas’s dividend payout ratio (DPR) is currently 378.18%.

Insider Activity

In other news, Director Michael J. Embler purchased 2,500 shares of Ventas stock in a transaction dated Wednesday, June 3rd. The shares were bought at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the transaction, the director directly owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This represents a 3.90% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on VTR shares. Weiss Ratings reiterated a “buy (b-)” rating on shares of Ventas in a research note on Wednesday. BMO Capital Markets restated an “outperform” rating and set a $100.00 price objective on shares of Ventas in a research report on Monday, May 4th. Citigroup raised their price objective on Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a research note on Friday, May 1st. UBS Group lifted their target price on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a research report on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $100.00 target price on shares of Ventas in a research note on Tuesday, June 16th. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $96.00.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.